Global Endorphins Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Endorphins Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Endorphins are also known as “feel-good” or natural pain relievers. They are produced by the central nervous system and pituitary gland. Endorphins are released in response to stress or pain. They work similarly to a class of drugs called opioids. However, endorphins work similarly to opioid pain reliver, but their result may not dramatic. Besides, they are also released during other activities such as exercise, eating and others activities. Endorphins are also surge during pregnancy. Further, there are various medicinal herbs such as Rhodiola roseal, is known to release beta-endorphins in the brain and also used against an anti-depressant.
Endorphins report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Endorphins market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Institutional Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Endorphins industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Endorphins key manufacturers include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Endo International Plc, Egalet Corp., Lannett Co. Inc., Pfizer and Johnson & Johnson, etc. Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Endo International Plc are top 3 players and held % sales share in total in 2022.
Endorphins can be divided into Alpha-Endorphins, Beta-Endorphins, Gamma-Endorphins and Sigma-Endorphins, etc. Alpha-Endorphins is the mainstream product in the market, accounting for % sales share globally in 2022.
Endorphins is widely used in various fields, such as Institutional Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Institutional Pharmacies provides greatest supports to the Endorphins industry development. In 2022, global % sales of Endorphins went into Institutional Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Endorphins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Endo International Plc
Egalet Corp.
Lannett Co. Inc.
Pfizer
Johnson & Johnson
Segment by Type
Alpha-Endorphins
Beta-Endorphins
Gamma-Endorphins
Sigma-Endorphins
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Endorphins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Endorphins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Endorphins industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Endorphins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Endorphins introduction, etc. Endorphins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Endorphins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Endorphins report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Endorphins market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Institutional Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Endorphins industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Endorphins key manufacturers include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Endo International Plc, Egalet Corp., Lannett Co. Inc., Pfizer and Johnson & Johnson, etc. Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Endo International Plc are top 3 players and held % sales share in total in 2022.
Endorphins can be divided into Alpha-Endorphins, Beta-Endorphins, Gamma-Endorphins and Sigma-Endorphins, etc. Alpha-Endorphins is the mainstream product in the market, accounting for % sales share globally in 2022.
Endorphins is widely used in various fields, such as Institutional Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Institutional Pharmacies provides greatest supports to the Endorphins industry development. In 2022, global % sales of Endorphins went into Institutional Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Endorphins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Endo International Plc
Egalet Corp.
Lannett Co. Inc.
Pfizer
Johnson & Johnson
Segment by Type
Alpha-Endorphins
Beta-Endorphins
Gamma-Endorphins
Sigma-Endorphins
Segment by Application
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Endorphins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Endorphins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Endorphins industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Endorphins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Endorphins introduction, etc. Endorphins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Endorphins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices